MENU
PYXS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Pyxis Oncology (PYXS) Ownership - Who owns Pyxis Oncology?
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients... Show more
Profile
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 221-9059
Employees
50
Web
https://www.pyxisoncology.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
73.1M
P/E Ratio
N/A
Total Cash
105.43M
Projected Growth
N/A
Total Debt
19.84M
Revenue
N/A
Risk (Beta)
0.84
Dividend Yield
N/A
Total Cash/Share
1.70
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
PYXS
Capitalization
73.1M
P/E Ratio
N/A
Risk (Beta)
0.84
Dividend Yield
N/A
Total Cash
105M
Total Cash/Share
1.70
Total Debt
19.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
103M
P/B Ratio
0.71
Cash Flow
N/A
Earnings
-1.61
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
62K
Current Ratio
7.75
Current Revenue Per Employee
316588.25
Dividends Per Share - Security
N/A
EBITDA
-83.39M
Float
N/A
Float - Current
N/A
Gross Income Margin
97.06
Revenue To Assets
-53.49
Shares Held By Institutions
42.5M
Shares Outstanding - Current
61.9M
Total Liabilities
32.8M
Total Volume MTD
N/A
Value
1
Gain YTD
-24.359
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
321 Harrison Avenue
Phone
+1 617 221-9059
Employees
50
Web
https://www.pyxisoncology.com